HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

OMCL

Omnicell, Inc. (NASDAQ)

Healthcare — Health Information Services

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Strong Buy 1.4 / 5 7 analysts
$41.93
+$0.41 (+0.99%)
Target: $61.29 (46.2%)
Sign in to add OMCL to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$1.91B
P/E Ratio (TTM)95.30
Forward P/E19.10
EPS (TTM)$0.44
Dividend Yield-
Profit Margin1.67%
Revenue Growth14.90%
ROE1.63%
Debt/Equity16.09
Recommendation Strong Buy 1.4
Analyst Target$61.29
Analysts7
Indexes NASDAQ

Technical Indicators

RSI (14)71.5
Beta0.96
SMA 20-
SMA 40-
52-Week High$55.00
52-Week Low$26.85
50-Day Avg$41.53
200-Day Avg$39.05
Avg Volume625.2K
Volume505.4K

Performance Analysis

NEUTRAL

OMCL presents a mixed picture with both positive and negative indicators.

~ Trading at 54% of its 52-week range.
- RSI at 71.5 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- P/E of 95.3 is elevated — the market expects high growth or it may be overvalued.
~ Modest revenue growth of 14.9% year-over-year.
+ Wall Street consensus is "Strong Buy" from 7 analysts.
+ Average analyst target of $61.29 implies 46.2% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:24 UTC

Back to Screener Export Report